Medical Devices Investors & VC Firms

1393 firms in this list, with a median first check of $500K. 266 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AD AdBio partners AHCBEGMA21 people	88🔒	Paris	FR	Pre-Seed–Series A	—	+ Add to CRM
IN Innovobot DGMVERJP30 people	88🔒	Montreal	CA	Pre-Seed–Series A	$182.5K – $365K	+ Add to CRM
FI First Analysis AWCGDLHS23 people · Leads rounds	88🔒	Chicago	US	Series A–Late Stage	—	+ Add to CRM
AN Angel Academe STSHYMKS15 people · Follows rounds	88🔒	London	GB	Seed–Series A	$11K – $385K	+ Add to CRM
BI BioGeneration Ventures OSDCEVKG27 people · Leads rounds	88🔒	Naarden	NL	Pre-Seed–Late Stage	—	+ Add to CRM
UC UCeed Funds Follows rounds	88🔒	Calgary	CA	Pre-Seed–Seed	$25K – $300K	+ Add to CRM
RE Red Tree Venture HLJCJCAS26 people · Leads rounds	88🔒	San Diego	US	Seed–Series B	—	+ Add to CRM
HI HighTechXL EGJBMBAT31 people · Follows rounds	88🔒	Eindhoven	NL	Pre-Seed–Seed	—	+ Add to CRM
PJ PJC MHRMSMDM9 people · Follows rounds	88🔒	Providence	US	Pre-Seed–Series A	$500K – $3M	+ Add to CRM
BO Boreal Ventures DCJSASAH29 people	88🔒	Montréal	CA	Pre-Seed–Series A	$2.2M	+ Add to CRM
NO Norrsken22 LNNKNWNA26 people · Leads rounds	88🔒	Johannesburg	ZA	Seed–Late Stage	—	+ Add to CRM
YU YuanBio Venture Capital JCGNJCKL8 people · Follows rounds	88🔒	Suzhou	CN	Seed–Growth	$3M – $73M	+ Add to CRM
SH ShangBay Capital LLC CSWDETMW13 people	88🔒	Palo Alto	US	Seed–Series A	—	+ Add to CRM
SI Signet Healthcare Partners JGAFNPAB13 people · Leads rounds	88🔒	New York	US	Growth–Late Stage	$10M – $50M	+ Add to CRM
VE VenturEast RASDSSSY12 people	88🔒	Bangalore	IN	Seed–Late Stage	—	+ Add to CRM
AP Apollo Health Ventures ABFHMMNR32 people · Leads rounds	88🔒	Berlin	DE	Seed–Series A	—	+ Add to CRM
CO Corewell Health Ventures CRKETBCH5 people	88🔒	Grand Rapids	US	Series B–Late Stage	—	+ Add to CRM
MH mHUB HAMMBFAL29 people · Follows rounds	88🔒	Chicago	US	Pre-Seed–Seed	$200K	+ Add to CRM
AL Alta Partners BMDJPHPH10 people	88🔒	Jackson	US	Seed–Growth	$1M – $12M	+ Add to CRM
AS Asabys Partners CCJLGMJM20 people · Follows rounds	88🔒	Madrid	ES	Seed–Growth	—	+ Add to CRM
AR Arkin Capital MANAALFP28 people	88🔒	Herzliya	IL	Seed–Late Stage	—	+ Add to CRM
BO Boulder Ventures JPKMKLPR6 people · Leads rounds	88🔒	Boulder	US	Series A	$1M – $4M	+ Add to CRM
VE venBio Partners RAARCGRG9 people · Follows rounds	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
KA Kaiser Permanente Ventures CGABBWJZ9 people	88🔒	San Francisco	US	Seed–Growth	$2M – $5M	+ Add to CRM

AdBio partners

ParisPre-Seed–Series A

AHCBEGMA21 people

Innovobot

MontrealPre-Seed–Series A$182.5K – $365K

DGMVERJP30 people

First Analysis

ChicagoSeries A–Late Stage

AWCGDLHS23 people

Angel Academe

LondonSeed–Series A$11K – $385K

STSHYMKS15 people

BioGeneration Ventures

NaardenPre-Seed–Late Stage

OSDCEVKG27 people

UCeed Funds

CalgaryPre-Seed–Seed$25K – $300K

Red Tree Venture

San DiegoSeed–Series B

HLJCJCAS26 people

HighTechXL

EindhovenPre-Seed–Seed

EGJBMBAT31 people

PJC

ProvidencePre-Seed–Series A$500K – $3M

MHRMSMDM9 people

Boreal Ventures

MontréalPre-Seed–Series A$2.2M

DCJSASAH29 people

Norrsken22

JohannesburgSeed–Late Stage

LNNKNWNA26 people

YuanBio Venture Capital

SuzhouSeed–Growth$3M – $73M

JCGNJCKL8 people

ShangBay Capital LLC

Palo AltoSeed–Series A

CSWDETMW13 people

Signet Healthcare Partners

New YorkGrowth–Late Stage$10M – $50M

JGAFNPAB13 people

VenturEast

BangaloreSeed–Late Stage

RASDSSSY12 people

Apollo Health Ventures

BerlinSeed–Series A

ABFHMMNR32 people

Corewell Health Ventures

Grand RapidsSeries B–Late Stage

CRKETBCH5 people

mHUB

ChicagoPre-Seed–Seed$200K

HAMMBFAL29 people

Alta Partners

JacksonSeed–Growth$1M – $12M

BMDJPHPH10 people

Asabys Partners

MadridSeed–Growth

CCJLGMJM20 people

Arkin Capital

HerzliyaSeed–Late Stage

MANAALFP28 people

Boulder Ventures

BoulderSeries A$1M – $4M

JPKMKLPR6 people

venBio Partners

San FranciscoSeed–Late Stage

RAARCGRG9 people

Kaiser Permanente Ventures

San FranciscoSeed–Growth$2M – $5M

CGABBWJZ9 people

Data sourced from public filings and firms' own websites — see our methodology.